Atlas Trials

Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy

Clinical trial NCT03332771 · COMPLETED

Trial details

NCT number
NCT03332771
Sponsor
Lexicon Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2017-12-01
Primary completion
2019-08-06
Enrollment
954

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.